Morgan Stanley Poseida Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 539,010 shares of PSTX stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

539,010

Previous 363,281 48.37%

Holding current value

$1.46 Million

Previous $1.06 Million 45.38%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.7 - $4.04 $474,468 - $709,945	175,729 Added 48.37%	539,010 $1.54 Million
Q2 2024 Oct 17, 2024	SELL	$2.0 - $3.46 $210,590 - $364,320	-105,295 Reduced 22.47%	363,281 $1.06 Million
Q2 2024 Aug 14, 2024	SELL	$2.0 - $3.46 $210,590 - $364,320	-105,295 Reduced 22.47%	363,281 $1.06 Million
Q1 2024 Oct 17, 2024	BUY	$2.76 - $4.13 $290,614 - $434,868	105,295 Added 28.98%	468,576 $1.49 Million
Q1 2024 Aug 16, 2024	BUY	$2.76 - $4.13 $350,346 - $524,249	126,937 Added 37.16%	468,576 $1.49 Million
Q1 2024 May 15, 2024	BUY	$2.76 - $4.13 $350,346 - $524,249	126,937 Added 37.16%	468,576 $1.49 Million
Q4 2023 Aug 16, 2024	SELL	$1.83 - $3.51 $39,604 - $75,963	-21,642 Reduced 5.96%	341,639 $1.15 Million
Q4 2023 Feb 13, 2024	BUY	$1.83 - $3.51 $114,340 - $219,308	62,481 Added 22.38%	341,639 $1.15 Million
Q3 2023 Nov 15, 2023	SELL	$1.62 - $2.79 $448,347 - $772,154	-276,758 Reduced 49.78%	279,158 $664,000
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.4 $122,989 - $251,906	74,090 Added 15.38%	555,916 $978,000
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $1.16 Million - $3.28 Million	375,739 Added 354.18%	481,826 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $121,971 - $233,686	36,628 Added 52.73%	106,087 $562,000
Q3 2022 Nov 14, 2022	SELL	$2.43 - $4.51 $7,567 - $14,044	-3,114 Reduced 4.29%	69,459 $245,000
Q2 2022 Oct 27, 2022	BUY	$1.87 - $5.0 $37,227 - $99,540	19,908 Added 37.8%	72,573 $188,000
Q2 2022 Aug 15, 2022	BUY	$1.87 - $5.0 $37,227 - $99,540	19,908 Added 37.8%	72,573 $188,000
Q1 2022 Oct 27, 2022	SELL	$3.22 - $7.04 $64,103 - $140,152	-19,908 Reduced 27.43%	52,665 $236,000
Q1 2022 May 13, 2022	BUY	$3.22 - $7.04 $25,299 - $55,313	7,857 Added 17.53%	52,665 $236,000
Q4 2021 Feb 14, 2022	BUY	$6.23 - $7.6 $61,384 - $74,882	9,853 Added 28.19%	44,808 $306,000
Q3 2021 Nov 15, 2021	BUY	$7.09 - $10.71 $247,830 - $374,368	34,955 New	34,955 $254,000

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.5M

Call Options Held

377K

Put Options Held

22.2K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $232M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account